Garth D. Nelson

2.9k citations

42 papers · 1.7k indexed · 1 hit paper · h-index 16

Impact in

Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer
- Lymphoma Diagnosis and Treatment
Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection

Papers in

Oncology 30
- Colorectal Cancer Treatments and Studies 14
- Colorectal Cancer Screening and Detection 9
- Colorectal Cancer Surgical Treatments 6
- Cancer Treatment and Pharmacology 4
- Lung Cancer Research Studies 4
Pathology and Forensic Medicine 13
- Genetic factors in colorectal cancer 9

Co-authors: Daniel J. Sargent Steven R. Alberts Richard M. Goldberg Qian Shi Axel Grothey Michelle R. Mahoney Frank A. Sinicrope Stephen N. Thibodeau
Journals: Journal of Clinical Oncology (16 papers)Cancer (3 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)Blood (2 papers)
Partner nations: United States Canada South Korea

In The Last Decade

Garth D. Nelson

40 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 2011 · 401 citations

Peers

Countries citing papers authored by Garth D. Nelson

Since Specialization

Citations

This map shows the geographic impact of Garth D. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garth D. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garth D. Nelson more than expected).

Fields of papers citing papers by Garth D. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garth D. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garth D. Nelson. The network helps show where Garth D. Nelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Garth D. Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Garth D. Nelson Line = papers co-authored together Garth D. Nelson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A randomized phase II trial of atezolizumab with or without tiragolumab before and after definitive chemoradiation for unresectable stage III non-small cell lung cancer (NSCLC; AFT-57). Journal of Clinical Oncology ·Helen J. Ross, David Kozono, Brailski Khr, James J. Urbanic, Terence M. Williams, T V O'Donnell, Ilze Bāra, Katja Schulze, Xiaofei F. Wang, Garth D. Nelson, Maysa M. N. Taha	2024	3
2	Radiation Quality Control in the PROSPECT Trial International Journal of Radiation OncologyBiologyPhysics ·Harvey J. Mamon, Qiuling Shi, K.S. Smith, Sung-Wook Nam, Michelle González Sánchez, Garth D. Nelson, Isabel Mota, Marc J. Gollub, Leonard B. Saltz, Ethan Basch, Amylou C. Dueck, Karyn A. Goodman, Thomas J. George, George J. Chang, Jeffrey M. Farma, Amandeep K. Shergill, 刘占芳, Eileen M. O’Reilly, 戴维民, Feng Siyang	2024	0
3	597P Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance) Annals of Oncology ·Martin R. Weiser, Qian Shi, George J. Chang, Julio González Candía, Joel E. Goldberg, Rebecca C. Auer, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher, Tareq Al Baghdadi, Jeffrey M. Farma, Thomas J. George, Sung-Wook Nam, Garth D. Nelson, Eileen M. O’Reilly, Ardaman Shergill, Jeffrey A. Meyerhardt, Harvey J. Mamon, Deborah Schrag	2023	1
4	569P Artificial intelligence for detection of mismatch repair deficiency in colon carcinomas (alliance) Annals of Oncology ·Frank A. Sinicrope, Garth D. Nelson, I. A. Filippov, Benny Setiyadi, Yoojoo Lim, Dongyao Yan, Kandavel Shanmugam, Steven R. Alberts, Qian Shi, 宗太郎深澤, Rish K. Pai, Poonam Devi	2023	0
5	ACCRU-GI-2008: A phase II randomized study of atezolizumab (Atezo) plus a multi-kinase inhibitor (MKI) versus MKI alone in patients with unresectable advanced hepatocellular carcinoma (aHCC) who previously received atezolizumab plus bevacizumab (Bev). Journal of Clinical Oncology ·Wen Wee, Fang‐Shu Ou, Jing Li, Nguyen H. Tran, Hani M. Babiker, Alexander Revzin, Haidong Dong, Garth D. Nelson, Andy Ness, Chongyang Li, Jingquan Jia, Tanios Bekaii‐Saab	2022	1
6	Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147 International Journal of Cancer ·Amanda I. Phipps, Qian Shi, Paul J. Limburg, Garth D. Nelson, Daniel J. Sargent, Frank A. Sinicrope, Emily Chan, Sharlene Gill, Richard M. Goldberg, Morton S. Kahlenberg, Suresh Nair, Anthony F. Shields, Polly A. Newcomb, Steven R. Alberts	2016	16
7	Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance) Clinical Cancer Research ·Frank A. Sinicrope, Michelle R. Mahoney, Harry H. Yoon, Thomas C. Smyrk, Stephen N. Thibodeau, Richard M. Goldberg, Garth D. Nelson, Daniel J. Sargent, Steven R. Alberts	2015	66
8	Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study Journal of Clinical Oncology ·Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Craig B. Reeder, James M. Foran, Garth D. Nelson, Carrie A. Thompson, Candido E. Rivera, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Randy D. Gascoyne, Thomas M. Habermann, Thomas E. Witzig	2014	268
9	A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621 Lung Cancer ·Julian R. Molina, Nathan R. Foster, Thanyanan Reungwetwattana, Garth D. Nelson, Zhao Zhang, Preston D. Steen, Philip J. Stella, Randolph S. Marks, James R. Wright, Alex A. Adjei	2014	37
10	Overall survival result and outcomes by KRAS, BRAF, andDNA mismatch repair in relation to primary tumor site in colon cancers from a randomized trial of adjuvant chemotherapy: NCCTG (Alliance) N0147. Journal of Clinical Oncology ·Frank A. Sinicrope, Harry H. Yoon, Michelle R. Mahoney, Garth D. Nelson, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Steven R. Alberts	2014	10
11	Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147 JNCI Journal of the National Cancer Institute ·Wilson I. Gonsalves, Michelle R. Mahoney, Daniel J. Sargent, Garth D. Nelson, Steven R. Alberts, Frank A. Sinicrope, Richard M. Goldberg, Paul J. Limburg, Stephen N. Thibodeau, Axel Grothey, Joleen M. Hubbard, Emily Chan, Suresh Nair, Jeffrey L. Berenberg, Robert R. McWilliams	2014	127
12	KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF –Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance) Clinical Cancer Research ·Harry H. Yoon, David Tougeron, Qian Shi, Steven R. Alberts, Michelle R. Mahoney, Garth D. Nelson, Suresh Nair, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Frank A. Sinicrope	2014	127
13	Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147 Journal of Clinical Oncology ·Amanda I. Phipps, Qian Shi, Polly A. Newcomb, Garth D. Nelson, Daniel J. Sargent, Steven R. Alberts, Paul J. Limburg	2013	44
14	Current Use and Surgical Efficacy of Laparoscopic Colectomy in Colon Cancer Journal of the American College of Surgeons ·Robert P. Sticca, Steven R. Alberts, Michelle R. Mahoney, Daniel J. Sargent, A. Land�, Garth D. Nelson, James J. Vouglitois, Jan Franko, Charles D. Goldman, Barbara A. Pockaj	2013	11
15	A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528 Journal of Thoracic Oncology ·Grace K. Dy, Sumithra J. Mandrekar, Garth D. Nelson, Jeffrey P. Meyers, Araba A. Adjei, (unknown), Helen J. Ross, Rafat Ansari, Alan P. Lyss, Philip J. Stella, Steven E. Schild, Julian R. Molina, Alex A. Adjei	2012	36
16	Prognostic web‐based models for stage II and III colon cancer Cancer ·Sharlene Gill, Charles L. Loprinzi, Hagen F. Kennecke, Axel Grothey, Garth D. Nelson, Ryan Woods, Caroline Speers, Steven R. Alberts, Aditya Bardia, Michael J. O’Connell, Daniel J. Sargent	2011	21
17	A randomized phase II study of gemcitabine (G) and carboplatin (C) with or without cediranib (AZD2171 [CED]) as first-line therapy in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Grace K. Dy, 瑞子望月, Garth D. Nelson, Helen J. Ross, Rafat Ansari, Alan P. Lyss, Philip J. Stella, Steven E. Schild, Julian R. Molina, Alex A. Adjei, (unknown)	2010	11
18	Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive‐stage small cell lung cancer, N0423 Cancer ·Cheng Ean Chee, James R. Jett, Albert M. Bernath, Nathan R. Foster, Garth D. Nelson, Julian R. Molina, Daniel A. Nikcevich, Preston D. Steen, Patrick J. Flynn, Kendrith M. Rowland	2010	3
19	Prognostic factors differ by tumor stage for small cell lung cancer Cancer ·Nathan R. Foster, Sumithra J. Mandrekar, Steven E. Schild, Garth D. Nelson, Kendrith M. Rowland, Richard L. Deming, Timothy F. Kozelsky, Randolph S. Marks, James R. Jett, Alex A. Adjei	2009	89
20	Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144 Clinical Colorectal Cancer ·Grace K. Dy, Timothy J. Hobday, Garth D. Nelson, Harold E. Windschitl, Michael J. O’Connell, Steven R. Alberts, Richard M. Goldberg, Daniel A. Nikcevich, Daniel J. Sargent	2009	59

About Garth D. Nelson

Garth D. Nelson is a scholar working on Oncology, Pathology and Forensic Medicine, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (9 papers), Colorectal Cancer Screening and Detection (9 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Surgical Treatments (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (716 citations), Oncology (1.1k citations), Emergency Medicine (224 citations), Reproductive Medicine (150 citations) and Hepatology (135 citations). Garth D. Nelson has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Daniel J. Sargent, Steven R. Alberts, Richard M. Goldberg, Qian Shi, Axel Grothey, Michelle R. Mahoney, Frank A. Sinicrope, Stephen N. Thibodeau, Barbara A. Pockaj and Jan Franko. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, Clinical Cancer Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact